Cancer patients monitored for years after experimental immune cell treatment
Disease control
ENROLLING_BY_INVITATION
This study follows 60 cancer patients who have already received SynKIR CAR T cell therapy to check for long-term side effects and see how well the treatment continues to work. Researchers will monitor for delayed reactions and measure survival over time. The goal is to understand…
Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC